Compare CRWS & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWS | RLYB |
|---|---|---|
| Founded | 1957 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 28.7M |
| IPO Year | 1994 | 2021 |
| Metric | CRWS | RLYB |
|---|---|---|
| Price | $2.57 | $8.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.5K | ★ 244.5K |
| Earning Date | 02-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 12.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,270,000.00 | $858,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 6.51 | ★ 43.00 |
| 52 Week Low | $2.35 | $0.22 |
| 52 Week High | $3.65 | $11.49 |
| Indicator | CRWS | RLYB |
|---|---|---|
| Relative Strength Index (RSI) | 32.40 | 57.93 |
| Support Level | $2.54 | $0.50 |
| Resistance Level | $2.94 | $11.49 |
| Average True Range (ATR) | 0.11 | 0.65 |
| MACD | -0.02 | -0.39 |
| Stochastic Oscillator | 21.57 | 40.09 |
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.